Skip to main content
. 2023 Feb 10;25(3):127. doi: 10.3892/ol.2023.13713

Figure 1.

Figure 1.

Comparing the serum anti-JMJD6 antibody levels between healthy controls and patients with colorectal cancer. This figure shows the levels of s-JMJD6-Abs examined using amplified luminescence proximity homogeneous assay-linked immunosorbent assay (AlphaLISA). A scatter dot plot of s-JMJD6-Abs (Alpha photon counts) is shown. Data are presented as the mean ± standard deviation. P-values were calculated using the Mann-Whitney U test. *P<0.05. The total sample numbers, a cutoff value are shown. The positive rate for patients with colorectal cancer was 37%, compared to 14% for healthy controls. s-JMJD6-Abs, serum antibodies against JMJD6.